Gastrointestinal tract tissue opacification via iodine-based radiodensity enhancement

The entry "Gastrointestinal tract tissue opacification via iodine-based radiodensity enhancement" does **not** refer to a specific molecular target such as a receptor, enzyme, transporter, or protein. Instead, it describes a *diagnostic imaging technique* that uses iodinated compounds as physical agents to increase the visibility ("opacification") of gastrointestinal tissues during X-ray-based procedures like CT scans and fluoroscopy. Iodine's high atomic number allows it to absorb X-rays more effectively than surrounding soft tissues. When administered orally or rectally for GI studies—or intravenously for vascular/organ imaging—iodinated compounds create areas of increased radiographic density on images by enhancing photoelectric absorption at energies near the k-edge of iodine (~33 keV). This results in clearer differentiation between anatomical structures and is crucial for detecting abnormalities such as tumors, inflammation, perforations, or strictures within the GI tract[1][5][7]. This process is not mediated by interaction with biological targets but rather exploits physical properties for diagnostic purposes. Therefore, this entry should not be considered a canonical therapeutic target. There are notable safety concerns associated with iodinated contrast use—including allergic reactions and nephrotoxicity—so patient selection and monitoring are important considerations[1][7]. In summary: this is *not* a molecular target but rather an imaging application using physical properties of iodine-containing agents; thus most structured fields do not apply.

Other names

Iodine-based radiodensity enhancement of gastrointestinal tract tissueGastrointestinal opacification with iodinated contrastGI tract iodine contrast imaging

Physical enhancement of X-ray attenuation via high atomic number element (iodine) leading to increased photoelectric absorption and improved radiographic contrast[1][5][7]